Mirum Pharmaceuticals, Inc. (MIRM)

80.05 -1.02 (-1.26%) USD  |  NASDAQ  |  Dec 23, 16:00
81.41 +1.36 (+1.70%) After-Hours: 07:01
More

Mirum Pharmaceuticals SG&A Expense (TTM): 239.73M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for MIRM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 13.91B
Arcutis Biotherapeutics, Inc. 253.18M
Insmed, Inc. 631.20M
CorMedix, Inc. 75.56M
ADMA Biologics, Inc. 96.37M